Enanta Pharmaceuticals Inc.

(ENTA) Trade

By |

Profile

Enanta Pharmaceuticals Inc is a biotechnology company. It is engaged in the research and development of small molecule drugs for infectious diseases. The Group uses its chemistry-driven approach & drug discovery capabilities to develop its products.

Contact Information

Website: www.enanta.com
Email: cmiceli@enanta.com
Main Phone: +1 617 607-0800
Address: 500 Arsenal Street
State: MA
City / Town: Watertown
Country: USA
Postal Code: 02472

Issuer Information

Exchange: NGS
CEO: Jay R. Luly
Employees: 89
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 92.41 $ -5.27 (-5.40%)
Last Price 92.41 Change $ -5.27 Change % -5.40 Tick N/A
Bid 24.44 Bid Size 100.00 Ask 100.00 Ask Size 300.00
Open 97.84 High 98.08 Low 91.58 Prev Close 97.68
Last Trade Volume 1.4 mi 52 Wk Hi 127.77 52 Wk Low 42.76
Market Cap 1.8 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 19,377,527.00 EPS (TTM) 4.07 PE Ratio 22.70 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 18 37
Number of Buys 2 15
Number of Sells 16 22
Net Activity -51470 -1807
Last 10 Buys Shares
Nathaniel S. Gardiner 1,000
Terry Vance 1,000
Stephen Buckley 1,000
Stephen Buckley 1,000
Nathaniel S. Gardiner 1,000
Nathaniel S. Gardiner 1,000
Nathaniel S. Gardiner 1,000
Stephen Buckley 1,000
Gregory L. Verdine 1,000
Terry Vance 1,000
Last 10 Sell Shares
Paul J. Mellett 1,000
Paul J. Mellett 1,000
Paul J. Mellett 1,000
Paul J. Mellett 1,000
Paul J. Mellett 1,000
Jay R. Luly 1,000
Nathalie Adda 1,000
Nathalie Adda 1,000
Nathalie Adda 1,000
Jay R. Luly 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 135 135 105 135
Low Target Price Estimate 82 82 58 82
Mean Target Price Estimate 111 105.5 81.67 111
Standard Deviation 22.68 22.01 23.5 22.68
Date of Most Recent Estimate 06/06/18 05/24/18 05/09/18 06/06/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 1 1 1
Moderate Buy 0 0 0 0
Hold 3 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2 2.5 2.5 2.5